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Sheep pulmonary adenomatosis ([SPA] ovine pulmonary carcinoma) is a transmissible lung cancer of sheep
that has been associated etiologically with a type D- and B-related retrovirus (jaagsiekte retrovirus [JSRV]).
To date it has been impossible to cultivate JSRV in vitro and therefore to demonstrate the etiology of SPA by
a classical approach. In addition, the presence of 15 to 20 copies of endogenous JSRV-related sequences
(enJSRV) has hampered studies at the molecular level. The aim of this study was to investigate whether the
expression of exogenous JSRV was specifically associated with neoplasia in SPA-affected animals. Initially, we
found that enJSRVs were transcribed in a wide variety of normal sheep tissues. Then, by sequencing part of the
gag gene of enJSRV we established a ScaI restriction site in gag as a molecular marker for the exogenous form
of JSRV. Restriction enzyme digestion of PCR products obtained from the amplification of cDNA from a total
of 65 tissues collected from SPA-affected and unaffected control sheep revealed that the exogenous form of
JSRV was exclusively and consistently present in tumor tissues and lung secretions of the affected animals. In
addition, exogenous JSRV provirus was detected only in DNA from SPA tumors and not from nontumor tissues
of the same animals. This study has demonstrated clearly that the exogenous form of JSRV is specifically
associated with SPA tumors.
Retroviruses are an invaluable model system for under-
standing carcinogenesis and the regulation of normal cell
growth. Studies of spontaneous retrovirus-induced animal and
human lymphomas have contributed immensely to our knowl-
edge of the onset of cancer (5), yet relatively little information
is available concerning retroviral causes and mechanisms of
epithelial cell neoplasms which, in humans, are much more
frequent than lymphomas (39).
Sheep pulmonary adenomatosis (SPA; also known as jaag-
siekte and ovine pulmonary carcinoma) represents a unique
model of a naturally occurring epithelial neoplasm which is
associated etiologically with a retrovirus (6, 35). Interestingly,
SPA shares certain characteristics with human bronchoalveo-
lar cell carcinoma (13, 29), which is only weakly associated with
smoking (10, 16, 21) and which has dramatically increased in
prevalence since 1955 and now represents 24% of lung cancers
(3).
Several lines of evidence implicate retroviral involvement in
the etiology of SPA. SPA has been reproduced experimentally
by inoculating sheep with cell-free lung secretions (lung fluid)
or tumor extracts from SPA-affected animals (7, 24, 36, 42).
These materials have been shown consistently to contain a
retrovirus with morphological, biochemical, and immunologi-
cal properties similar to type D and B retroviruses (20, 30, 32,
38). This virus, known as jaagsiekte retrovirus (JSRV; also
known as SPA retrovirus and ovine pulmonary carcinoma ret-
rovirus), exhibits the typical genomic organization of a repli-
cation-competent retrovirus with long terminal repeat (LTR),
gag, pro, pol, and env regions and no apparent sequences com-
monly associated with transformation (43). Despite the clear
association between JSRV and pulmonary adenomatosis, clas-
sical approaches to demonstrate an etiological role for this
virus have been hampered by the lack of a cell culture system
to propagate JSRV.
Recently, the link between JSRV and SPA was strengthened
further by the demonstration that lung and transformed pul-
monary epithelial cells of SPA-affected sheep are major sites of
virus replication. JSRV particles or antigens have never been
detected in tissues of unaffected control sheep (27). In addi-
tion, the presence of 15 to 20 copies of endogenous JSRV-
related sequences (enJSRV) in the normal sheep genome has
hampered analysis at the molecular level (19, 43). No infor-
mation is available about enJSRV sequences and their degree
of similarity with the exogenous JSRV. Therefore, the possi-
bility cannot be excluded that expression of the exogenous
virus in neoplastic cells is the result of the reactivation of an
enJSRV as a downstream event of the neoplasia.
The aim of this study was to investigate expression of JSRV
in tumor tissues and whether it is specifically associated with
neoplasia. Initially, the expression of JSRV-related sequences
in tissues of SPA-affected and unaffected control sheep was
determined by reverse transcription-PCR (RT-PCR). Differ-
entiation between exogenous and endogenous RNA species
was evaluated by sequencing and/or restriction enzyme diges-
tion of PCR products obtained from viral pellets and tumors of
SPA-affected sheep and tissues of unaffected sheep. Compar-
ison between tumor and nontumor genomic DNA collected
from the same SPA-affected animals was then performed in
order to determine whether the exogenous proviral JSRV was
detectable only in genomic DNA from tumor tissues.
MATERIALS AND METHODS
Sources and preparation of samples. In this study, SPA-affected sheep were
defined as animals which showed typical clinical signs, particularly the produc-
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tion of abundant seromucoid fluid (lung fluid) from the nostrils when the rear
limbs were elevated above the head. Diagnosis was confirmed by macroscopic
and histological examination of the lungs. Both naturally SPA-affected animals
and lambs infected by intratracheal inoculation of concentrated lung fluid, as
previously described (36), were used in this study. In addition, age- and breed-
matched controls were employed.
A total of 16 lung fluid samples were collected during clinical examinations of
SPA-affected sheep and processed as already described (38). Briefly, 5 to 10 ml
of lung fluid was filtered through a double layer of gauze and clarified by
centrifugation at 10,0003 g for 1 h at 48C. The supernatant was then centrifuged
at 100,000 3 g through a double layer of glycerol (25 and 50% [vol/vol]) for 1 h
at 48C, and the resultant pellet was resuspended in 500 ml of solution D (4 M
guanidinium thiocyanate, 25 mM sodium citrate [pH 7], 0.5% sarcosyl, 0.1 M
b-mercaptoethanol) and stored at 2208C until use. Leukocytes were obtained
from 10 blood samples in which the erythrocytes had been lysed. A total of 107
cells for each sample were resuspended in 500 ml of solution D and stored at
2208C.
Tissues from five lung tumors, four normal lungs, eight mediastinal lymph
nodes, five thymus glands, six bone marrow samples, five spleens, and six kidneys
of both SPA-affected and unaffected sheep were collected at postmortem exam-
ination (Table 1) and snap-frozen in liquid nitrogen before storage at 2708C.
Dog lung tissues were treated as the sheep tissues and used as negative controls.
An equine dermis cell line and primary fetal lamb lung and kidney cells were
employed as further controls in this study. Cells (107) were resuspended in 500
ml of solution D and stored at 2208C.
RNA extraction. Total RNA from ultraspeed pellets of lung fluid (2.5 to 5.0
ml), sheep tissues, and dog lung tissues (0.2 to 0.5 g), leukocytes, equine dermis
cells, and fetal lamb lung and kidney cells (107 cells) was extracted by the acid
guanidinium thiocyanate-phenol-chloroform method (4). Each RNA sample was
treated with 10 U of DNase I, RNase free (Boehringer), as suggested by the
manufacturer.
DNA extraction. High-molecular-weight genomic DNA was extracted by es-
tablished procedures (34) from lung tumor and kidney samples from four of the
five SPA-affected animals and from lung and kidney tissues from three of the
four unaffected controls. DNA was also isolated from primary cultures of normal
sheep skin fibroblasts for analysis of the LTRs (see below). Briefly, pulverized
tissue or cell pellets were lysed in TES buffer (10 mM Tris, 0.1 M EDTA, 0.5%
sodium dodecyl sulfate [pH 8]) followed by digestion with RNase A (Sigma; 20
mg/ml) for an hour at 378C with gentle mixing, then 100 ml (20 mg/ml) of
proteinase K was added and incubated at 608C overnight. Separate phenol and
chloroform-isoamyl alcohol (24:1) extractions were followed by isopropanol pre-
cipitation. High-molecular-weight DNA was harvested by spooling it onto glass
pipettes and was washed twice with 70% ethanol on ice, dried, resuspended in
TE buffer (10 mM Tris, 1 mM EDTA [pH 8]), and stored at 48C.
RT-PCR (gag). Synthesis of cDNA was carried out in 25-ml reaction volumes
as follows. Total RNA (2 mg from tissues, leukocytes, and cell culture samples or
total RNA obtained from ultraspeed pellets of 5 to 10 ml of lung fluid) was
diluted in 13.5 ml of diethyl pyrocarbonate-treated distilled water. RNA was
denatured at 658C for 10 min and then cooled on ice. One microliter (40 U) of
rRNAsin (Promega)–2 ml of 25 mM each deoxynucleoside triphosphate (dNTP)–
2.5 ml of 100 mM dithiothreitol–2.5 ml (A260, 62.5 U/ml [Boehringer]) of random
hexamers–2.5 ml of 103 reaction buffer (500 mM Tris-HCl [pH 8.3], 75 mM KCl,
3 mM MgCl2)–1 ml of StrataScript reverse transcriptase (50 U; Stratagene) was
added. The addition of the reverse transcriptase was omitted in control samples
to check for DNA contamination of the RNA preparations. The reaction mixture
was incubated at 378C for 1 h, and then the enzyme was inactivated by incubation
at 948C for 3 min.
Amplification of the resultant cDNA was carried out by PCR. Primers were
designed on the basis of the complete sequence of JSRV (43) and the pCA1
sequence of gag (19). Primers P1 and P2 (Fig. 1A) spanned a 229-bp region
internal to the gag gene (position 1598 to 1826 of JSRV) (43) (sense [P1],
59-GCTGCTTTRAGACCTTATCGAAA-39; antisense [P2], 59-ATACTGCAG
CYCGATGGCCAG-39). Three microliters of cDNA was added to 47 ml of 13
PCR buffer (1.25 U of Taq polymerase [Boehringer], 2.75 mM MgCl2, 50 mM
KCl, 10 mM Tris-HCl, 200 mM each dNTP, 6.25 pmol of each primer). PCR
cycles employed were 948C for 1 min and 35 cycles of 948C for 45 s, 578C for 1
min, and 728C for 1 min, with a final extension of 728C for 2 min in a Perkin-
Elmer GenAmp 2400 thermal cycler.
PCR was optimized for the detection of 1 to 10 copies of target DNA, using
plasmid pJS382 (courtesy of G. Querat) containing part of the JSRV gag gene
(nucleotide 953 to 3029) as template. Amplified products were detected by
electrophoresing 25-ml aliquots through a 2% agarose gel in 13 TBE buffer in
the presence of 0.5 mg of ethidium bromide per ml.
The products of five independent PCR-gag procedures with kidney cDNA
from an unaffected sheep were pooled before being cloned in pGEM-T (Pro-
FIG. 1. PCR strategy and localization of primers employed in this study. (A)
RT-PCR (gag), employing primers P1 and P2, amplified a product of 229 bp. (B)
PCR for the amplification of endogenous LTRs employed primers P3 and P4 and
generated products of 442 to 444 bp. (C) Heminested LTR-gag PCR. The first
round of amplification used primer P5 (internal to the LTR) and gag primer P2.
One microliter of this reaction mixture was used in the second round of ampli-
fication, which used primers P1 and P2.











Lung fluid 16/16 16/16
Tumor/lung 5/5 5/5 4/4 4/0
Kidney 3/3 3/0 3/3 3/0
Thymus 2/2 2/0 3/3 3/0
Bone marrow 3/3 3/0 3/3 3/0
Spleen 2/2 2/0 3/3 3/0
Mediastinal lymph node 5/5 5/3 3/3 3/0
Leukocytes 5/5 5/0 5/5 5/0
Total 41/41 41/24 24/24 24/0
a SPA-affected sheep.
b Unaffected control sheep.
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mega), following the manufacturer’s protocol. Seven clones were selected and
sequenced with the T7 sequencing kit (Pharmacia), as recommended by the
manufacturer.
Restriction enzyme digestion. Twenty-five microliters of the PCR-gag product
was digested with 13 U of ScaI (Boehringer), employing the appropriate incu-
bation buffer supplied by the manufacturer (PCR buffer was ignored), at 378C for
2 to 4 h. The digestion products were analyzed alongside the corresponding
mock-digested PCR products, by electrophoresis in a 2% agarose gel stained
with ethidium bromide.
Amplification and sequencing of endogenous LTRs. One hundred nanograms
of high-molecular-weight genomic DNA isolated from sheep skin fibroblasts was
used for PCR amplification of endogenous LTRs (PCR-LTR). Primers (Fig. 1B)
were designed at the 59 end of U3 (sense [P3], CTGCGGGGGACGAC, position
7179 to 7193 [43]) and at the 39 end of U5 (antisense [P4], CTGCCGCGAC
CAGCA, position 111 to 125 [43]). The buffer employed was 10 mM Tris (pH
8.9), 50 mM KCl, 2 mMMgCl2, with 200 mM each dNTP, 100 ng of primers, and
1 U of Taq (Boehringer). PCR cycles employed were an initial step of 948C for
2 min and then 40 cycles of 948C for 1 min, 588C for 1 min, 728C for 1 min, with
a final extension of 728C for 2.5 min.
The products of three independent PCRs were pooled and then cloned in the
TA cloning system (Invitrogen), according to the manufacturer’s instructions.
Three resultant clones were sequenced by the dideoxy chain termination method,
employing a Li-Cor automated sequencer.
Heminested LTR-gag PCR. In the first round of amplification, 250 to 500 ng of
tumor and kidney high-molecular-weight DNA was amplified by PCR, employing
the Expand Long Template PCR system (Boehringer), which uses a mixture of
Taq and Pwo DNA polymerases. The sense primer (P5, TGGGAGCTCTTTG
GCAAAAGCC, nucleotide position 7210 to 7224 [43]) was designed on the basis
of nucleotide sequence differences between the endogenous LTR sequences (1)
and the JSRV sequence (43). Primer P2 was employed as antisense primer (Fig.
1C). Reactions were carried out in a 50-ml volume containing 50 mM Tris-HCl
(pH 9.2), 160 mM (NH4)2SO4, 2.25 mMMgCl2, 2% (vol/vol) dimethyl sulfoxide,
0.1% (vol/vol) Tween 20, 500 mM each dNTP, 300 nM each primer, template
DNA, and 2.625 U of enzyme mix. Cycles were as follows: 1 cycle at 928C for 2
min; 30 cycles at 928C for 10 s, 618C for 30 s, and 688C for 90 s (plus a progressive
increment of 20 s from cycle 11 onward); and a final extension of 688C for 7 min.
One microliter of the product of the first round of amplification was used in
the second round of PCR which was the same as the PCR-gag procedure de-
scribed above. Half the product of the second-stage PCR was digested with ScaI
as described above.
Products of the first and second rounds of heminested PCR were visualized by
electrophoresis in 1 and 2% agarose gels, respectively.
Nucleotide sequence accession numbers. The nucleotide sequences of the
PCR clones of enJSRV gag fragments and LTRs are deposited in GenBank under
accession numbers Z49800, X92180, X92181, X92182 (enJSRV gag1 to -4) and
Z66531, Z66532, Z66533 (enJSRV LTRs 1 to 3).
RESULTS
Detection of enJSRV gag transcripts and differentiation be-
tween endogenous and exogenous transcripts. RT-PCR (gag),
using the primer pair P1 and P2, was used to examine respi-
ratory and other tissues from both SPA-affected and unaf-
fected sheep for the presence of JSRV gag transcripts. The
results are summarized in Table 1.
A product of the expected size (229 bp) was detected in all
65 sheep tissue samples tested. Primary cultures of fetal lamb
and kidney cells produced the same visible amplimer, whereas
dog lung tissues and an equine dermis cell line were consis-
tently negative. To exclude DNA contamination in the total
RNA preparations, the same samples were tested in parallel,
omitting reverse transcriptase from the reaction mix; no signal
was obtained from any of these samples.
The specificity of the amplimers was confirmed by Southern
hybridization with an oligonucleotide probe from a region of
JSRV gag internal to the PCR product (data not shown).
Previous studies have shown consistently that lung fluid and
lung tumor tissues from SPA-affected sheep contain JSRV
particles and antigens (18, 20, 27, 38); therefore, it may be
assumed that the RNA detected in these materials is of ex-
ogenous origin, while the RNA detected from tissues of
unaffected control animals is transcribed from endogenous se-
quences. RT-PCR using primers P1 and P2 therefore demon-
strated that transcripts of endogenous origin are widely ex-
pressed in sheep tissues.
To identify possible differences between endogenous and
exogenous RNA, the RT-PCR products obtained from kidneys
of an unaffected control animal were cloned and sequenced.
Seven clones were sequenced, and four different sequences
(enJSRV gag1 to -4) were obtained.
The four enJSRV sequences were compared with each other
and with the published exogenous sequences of JSRV (43)
(South African isolate) and pCA1 (19) (Peruvian isolate) by
computer analysis using the GCG Pileup program (14) (Fig. 2).
The South African and the Peruvian isolates were 90% similar
in the stretch of sequence considered. The enJSRV clones were
highly homologous to each other (95 to 99% similarity), 95 to
98% similar to the South African isolate, and 85 to 88% similar
to the Peruvian isolate. Comparison of the restriction maps of
the six sequences revealed a ScaI restriction site in JSRV and
pCA1 that was absent in all the enJSRV clones. To confirm this
observation, RT-PCR products from 16 lung fluid samples and
44 nontumor tissues were digested with ScaI. Successful diges-
tion, indicated by the presence of two smaller fragments of 131
and 98 bp, was observed with all 16 lung fluid samples, 5 of 5
tumors, and faintly in 3 of 5 mediastinal lymph nodes from
SPA-affected sheep. No ScaI-sensitive product was observed
with any other tissue (Fig. 3).
These findings confirm the complete correlation between
the ScaI site and the exogenous virus.
FIG. 2. Comparison of enJSRV gag sequences and exogenous pCA1 (19) with JSRV (43). Indicated are base differences with JSRV. Primers used are underlined,
while the boldface bases indicate the exogenous-specific ScaI site.
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Amplification and sequencing of endogenous LTRs. PCR
products of approximately 450 bp were obtained from the
amplification of DNA from cultured sheep primary skin fibro-
blast cultures by employing primers P3 and P4. Products were
cloned as described in Materials and Methods, and three
clones were completely sequenced (Fig. 4).
The enJSRV LTRs appeared to be longer (442 to 445 bp)
than the published exogenous LTR (397 bp) which showed
two large deletions of 30 and 16 bp at positions 198 and
261, respectively (nucleotide positions as in Fig. 4). The nucle-
otide sequences of the three enJSRV LTRs were 83 to 90%
identical and were 69 to 76% similar to the JSRV LTR se-
quence (43).
Detection of exogenous JSRV in tumors of SPA-affected
sheep. PCR products obtained by direct amplification of tu-
mor genomic DNA with primers P1 and P2 followed by
ScaI digestion did not show any cut product by electrophoresis
in an agarose gel stained with ethidium bromide, and hybrid-
ization of Southern blots with an internal probe did not resolve
this issue (data not presented). The failure to detect ScaI-
sensitive sequences at the DNA level may be due to the high
proportion of endogenous template compared with exogenous
template, resulting in a small proportion of ScaI-sensitive
product. Theoretically, there may be 20 endogenous copies
compared with possibly only 1 exogenous copy per neoplastic
cell. Moreover, neoplastic cells are approximately only 40 to
50% of the total number of cells present in the neoplastic
tissue, therefore increasing the ratio of endogenous to exoge-
nous sequences.
To preferentially amplify exogenous proviral DNA se-
quences (with the ScaI restriction site) we designed a hemi-
nested PCR. The first round of amplification used a sense
primer (P5) based on an area of sequence divergence between
endogenous LTR clones and the exogenous LTR sequence
(JSRV) and the antisense primer (P2) of the RT-PCR (gag). A
product of about 2 kb was visible in an ethidium bromide
agarose gel from three of four SPA tumor DNAs, while no
signal was obtained in four of four kidney DNAs of the same
animals or from lung and kidney tissues of three unaffect-
ed control animals. A second round of amplification, using
primers of the RT-PCR (gag) followed by ScaI digestion, en-
abled the detection of ScaI-sensitive sequences in all four tu-
mors examined, while only spurious bands were detected
in nontumor samples of SPA-affected or nonaffected sheep
(Fig. 5).
FIG. 3. Typical results of RT-PCR, followed by ScaI digestion, of total RNA
from SPA-affected sheep tissues. Samples: 1, lung fluid; 2, lung tumor; 3, medi-
astinal lymph nodes; 4, kidney (samples 1 to 4 were collected from the same
animal). Lanes: U, mock-digested PCR products; C, PCR product digested with
ScaI; M, molecular weight marker IX (Boehringer).
FIG. 4. Sequence alignment of enJSRV LTR clones with the JSRV LTR (43). Letters indicate differences with the consensus sequence. A period (.) indicates
deletions. Primers used to obtain enJSRV clones are underlined.
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DISCUSSION
This study has provided compelling lines of evidence which
collectively demonstrate a specific association between the ex-
ogenous forms of JSRV and SPA.
It was shown clearly that the exogenous form of JSRV was
distinct from endogenous JSRV transcripts as identified by the
presence of a ScaI restriction site in gag (nucleotide position
1729 [43]). Furthermore, this site was conserved in strains of
exogenous JSRV obtained from geographically dispersed
countries, supporting data linking these viruses to each other
and to SPA (18, 20, 27, 28, 33, 38).
Exogenous JSRV RNA was found only in tumors, lung fluid,
and draining lymph nodes of SPA-affected sheep, which is in
agreement with results of an earlier immunological study,
which concluded that epithelial tumor cells are major sites of
replication for JSRV (27). Lung fluid and tumor tissues from
SPA-affected sheep are the only materials that have been used
successfully to reproduce the tumor experimentally in sheep
and goats (7, 24, 36, 37, 42). These findings, therefore, point to
exogenous JSRV as a strong candidate for the etiological agent
of SPA, although they do not rule out possibilities such as
reactivation of an enJSRV as a downstream event of neoplasia.
However, the demonstration of exogenous JSRV provirus only
in tumor DNA provides irrefutable evidence that this virus is
specifically associated with neoplasia. Endogenous JSRV tran-
scripts were present in a wide variety of tissues from both
SPA-affected and unaffected sheep, although downstream
translation may be very low or absent, because CA protein was
not detected in nontumor tissues (27).
Nevertheless, the presence of transcriptionally active enJSRVs
raises a question about their potential role in SPA. In mice,
chickens, and cats, endogenous retroviruses have been dem-
onstrated to be involved in recombinational events leading to
the generation of oncogenic retroviruses or viruses with a
broader host range (2, 12, 15, 25, 41). The possibility of re-
combinational events between the exogenous form of JSRV
and its endogenous homologs cannot be ruled out. To clarify
this point, further characterization of endogenous and exoge-
nous JSRV sequences will be essential as limited sequence
data are available (19, 43).
Comparison of LTR sequences between JSRV and three
enJSRV clones derived from sheep skin fibroblasts revealed
differences in putative enhancer sites. A putative NF-1 motif in
exogenous JSRV LTR (nucleotides 7220 to 7223), which over-
laps the exogenous-specific PCR primer P5, is altered and/or
lost in the endogenous LTRs, and two tandemly repeated
sequences (positions 7347 to 7365 and 7366 to 7384 in the
JSRV sequence [43]) appear to be lost by means of an inser-
tion of 30 nucleotides in the endogenous U3. Differences in the
nucleotide sequences in these regions could potentially dimin-
ish the LTR function (8, 9, 11, 12, 17, 22, 23, 26, 31, 40) and
thus reduce the pathogenicity of enJSRVs compared with the
exogenous counterpart, as demonstrated in other retroviral
systems.
An interesting finding of this study was the detection of
exogenous JSRV RNA in three of five mediastinal lymph
nodes of SPA-affected sheep. Previous immunological studies
detected JSRV particles in only 1 of 12 regional lymph nodes
of SPA-affected sheep (27). The detection of the exogenous
JSRV in the majority of regional lymph nodes by RT-PCR may
reflect the presence of metastases, although these were not
detected by histological examination (data not shown), or may
reflect the presence of the virus in the lymph drained by the
regional lymph nodes at levels below the detection limit of the
immunological techniques. Because of the lack of data on the
immune response to JSRV, we cannot determine whether the
presence of JSRV in the lymph nodes is related to an active
immune response to the virus.
FIG. 5. Detection of exogenous JSRV sequences in tumor and kidney DNAs of the same SPA-affected sheep. Lanes 1 to 5 represent experiments performed with
lung tumor genomic DNA. Lanes: 1, 500 ng of lung tumor genomic DNA amplified directly by PCR-gag, employing primers P1 and P2; 2, PCR product shown in lane
1 cut with ScaI; 3, first round of amplification of heminested LTR-gag PCR, employing primers P5 and P2; 4, second round of amplification, employing primers P1 and
P2, of 1 ml of the PCR product shown in lane 3; 5, PCR product of lane 4 cut with ScaI. Lanes 6 to 10 represent experiments performed with kidney genomic DNA.
Lanes: 6, 500 ng of kidney genomic DNA amplified directly by PCR-gag, employing primers P1 and P2; 7, PCR product of lane 6 cut with ScaI; 8, first round of
amplification of heminested LTR-gag PCR, employing primers P5 and P2; 9, second round of amplification, employing primers P1 and P2; 10, PCR product shown in
lane 10 cut with ScaI. Lane 11 contains a negative control, lanes M contain Boehringer molecular weight markers VI (left) and IX (right).
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To date, JSRV has not been isolated in vitro, and therefore
classical approaches to demonstrate the etiology of SPA have
been impossible. However, the results reported in this commu-
nication show that exogenous JSRV is consistently and exclu-
sively demonstrated in tumors and lung fluids, which have been
used as inocula to induce SPA on numerous occasions (7, 24,
36, 42).
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